Intrinsiqq
Harvard Apparatus Regenerative Technology Inc. logo

Harvard Apparatus Regenerative Technology Inc. Insider Trading

HRGN

⊜ Compare
Last 12 months

Insiders bought 400K on the open market and sold nothing.

Net open-market
+400K
2 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Sep 2026
Sep 15, 2026

Get an email when HRGN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 11 – 15
    Junli He
    CEO · bought 368,630 at avg $1.07
    394K
    38% of stake
  • Nov 25, 2025
    Junli He
    CEO · bought 3,000 at $1.70
    5K
    1.1% of stake
  • Sep 30, 2025
    Junli He
    CEO · bought 300 at $1.98
    $594
    0.1% of stake
  • Sep 2, 2025
    Junli He
    CEO · bought 11,225 at $1.85
    21K
    4.2% of stake
  • Aug 21, 2025
    Junli He
    CEO · bought 4,050 at $1.72
    7K
    1.5% of stake
  • Dec 24, 2024
    Junli He
    CEO · bought 2,299 at $2.87
    7K
    0.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HRGN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with HRGN

CompareIntrinsic value
EMEDElectromedical Technologies Inc.
$0.00+0.00%26
VTAKCatheter Precision, Inc.
$0.56-5.08%40
PETVPetvivo Holdings Inc
$0.60+1.69%26
PLSEPulse Biosciences, Inc.
$57.06+9.31%40
CODXCo-Diagnostics Inc.
$0.36-5.00%10
SINTSintx Technologies Inc.
$1.66-3.49%10
LYRALyra Therapeutics Inc.
$0.19+0.00%0
EBRCZEBR Systems, Inc.
$0.08+0.00%0

Spot a number that looks wrong? Check it in HRGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HRGN

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.